Given their palatability, tolerability and availability, dried plums should be considered the initial approach to the management of mild to moderate constipation in the general population, according to results of a randomized…
Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome
The Montreal Heart Institute will be conducting the Phase 2 study of CER-001, an HDL mimetic The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions…
Hospitals with higher diagnosis frequency for chronic conditions have lower case-fatality rate
An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as…
New study on how epoxyeicosatrienoic acids protect kidneys
Researchers at Georgia Health Sciences University are studying whether inhibiting an enzyme that reduces levels of a protective metabolite could halt the progression of diabetic nephropathy, or kidney disease resulting from diabetes….
Protein folding may aid in development of new therapies for brain diseases
Misfold an origami swan and the worst that happens is you wind up with an ugly paper duckling. Misfold one of the vital proteins in your body – each of which must…
UNAIDS/UNDP/WHO Concerned Over Sustainability And Scale Up Of HIV Treatment
The Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Development Programme (UNDP) and the World Health Organization (WHO) are deeply concerned about the long-term sustainability of access to affordable HIV…
Genesis Biopharma to establish Adoptive Cell Immunotherapy based therapeutic development program
Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it is expanding its therapeutic strategy to include active immunotherapies to treat various cancers. The Company…
Researchers find first-generation x-rays more effective than today’s systems
Researchers recently tested first-generation x-ray equipment from 1896 and found that it produced radiation doses and exposure times that were vastly higher than those of today’s systems, according a study published online…
Brain Tumor Caused By Single Gene Defect
Pilocytic astrocytoma, the most common brain tumor in children, is usually slow-growing and benign. However, surgeons often cannot completely remove the diffusely growing tumor. This means that patients need further treatment in…
ERYtech Pharma To Present Promising Results For The Treatment Of Sickle Cell Disease
ERYtech Pharma will in the near future present their promising results obtained with the GR-ARA1 project for the treatment of sickle cell disease. Four oral communications will be given at major specialist…
Dubai Health Authority and Dubai Municipality sign MoU for accreditation of laboratories
The Dubai Health Authority (DHA) signed a memorandum of understanding (MoU) today with the Dubai Municipality to recognize the accreditation given by the municipality to laboratories in the Emirate of Dubai. With…
New Vaccine Candidate Shows Strong Potential Against Norovirus
Scientists have shown that an experimental vaccine against the human norovirus – the bug behind about 90 percent of highly contagious nonbacterial illnesses that cause diarrhea and vomiting – can generate a…
Acne Is More Than A Nuisance For Some Teens
America’s prom season is on the horizon and with it comes distress for thousands of teens who will be distraught to see a pimple raise its ugly head on their nose or…
New Approaches To Dementia And Sight Loss – Report Of First National Conference Released Today, UK
Key messages for professionals, policy makers, commissioners and carers are highlighted in a report released today (1) of the First National Conference on Dementia and Sight Loss. The report, by the Dementia…
Euthymics Bioscience Initiates Triade Trial For Major Depression
Euthymics Bioscience, Inc. announced the initiation of an advanced clinical study of its lead product candidate EB-1010 for the treatment of major depressive disorder (MDD). The TRIADE (Triple Reuptake Inhibitor Anti-Depressant Effects)…